期刊文献+

甲型H1N1流感危重症患儿的临床特征与救治策略

Treatment strategy and clinical features of critically ill children with influenza A H1N1
原文传递
导出
摘要 目的总结甲型H1N1流感诊疗危重病例临床特点与救治策略。方法回顾性总结15例患儿甲型H1N1流感危重症病例的临床特点和救治策略,采用RT-PCR方法检测甲型H1N1流感病毒核酸(咽拭子标本)。结果基础疾病或高危因素仅占20.0%,所有患儿均有咳嗽和发热;奥司他韦抗病毒治疗,危重病例剂量加倍,疗程为5~10 d;80.0%患儿3 d内体温恢复正常,20.0%患儿5 d内体温恢复正常,全部病例临床治愈。结论儿童甲型H1Nl流感危重病例,应用奥司他韦抗病毒安全有效,对危重病例或合并胸膜炎者可考虑短期小剂量糖皮质激素,常规应用新鲜冰冻血浆等。 OBJECTIVE To summarize the clinical features and experience by treatment of severe Influenza A H1N1. METHODS The treatments for 15 children with influenza A H1N1 who were critically ill were reviewed and summarized. The clinical characteristics and treatment strategy were summarized, Influenza A H1N1 virus nucleic acid (throat swab specimens) were detect by RT-PCR. RESULTS The underlying diseases or risk factors accounted for 20.0%. All the sick children have a cough and fever. 20.0% cases of critically ill patients were 5 years of age. Oseltamivir was used to anti-viral therapy, critical illness dose is double for 5-10 days. 80.0% cases of body temperature returned to normal within 3 days; 20.0% cases of body temperature returned to normal within 5 days. All patients were clinically cured. CONCLUSION Regardless of long duration or fever, the application of oseltamivir is safe and effective in children with severe influenza A (H1N1)/critical illness. Severe cases or merger of pleurisy may consider short-term low-dose glucocorticoid and conventional fresh frozen plasma.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第4期671-673,共3页 Chinese Journal of Nosocomiology
关键词 患儿 甲型H1N1流感 危重症病例 临床特点 救治策略 Ill childrem Influenza A HINI Critical medical cases Clinical feature Treatment strategy
  • 相关文献

参考文献4

二级参考文献14

  • 1Pandemic ( H1N1 ) 2009-update 58 (EB/OL) . World Health Organization ,2009 [ 2009-07-06 ]. http ://www. who. int/csr/don/ 2009 07 06/en,/index. html.
  • 2Peiris JS, Poon LL, Guan Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol, 2009,45 : 169-173.
  • 3ECDC working group on influenza A (H1N1)v. Preliminary analysis of influenza A (H1N1)v individual and aggregated case reports from EU and EFTA countries. Euro Surveill,2009,14:19238.
  • 4Novel swine-origin influenza A (HINI) virus investigation team, Dawood FS, Jain S, el al. Emergence of a novel swine-origin influenza A (HI N1 ) virus in humans. N Engl J Meal,2009,360: 2605 -2615.
  • 5Koliou M, Soteriades ES, Toumasi MM, et al. Epidemiological and clinical characteristics of influenza A ( H1N1 ) v infection in children: The first 45 cases in Cyprus, June-August 2009. Euro Surveill,2009,14 : 19312.
  • 6Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al. Pneumonia and respiratory failure from Swine-Origin influenza A (H1N1) in Mexico. N Engl J Med,2009,361:680-689.
  • 7Centers for Disease Control and Prevention . Intensive-care patients with severe novel influenza A ( H1N1 ) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep, 2009, 58:749-752.
  • 8Jamieson DJ, Honein MA, Rasmussen SA, et al . H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet, 2009,374: 451-458.
  • 9Centers for Disease Control and Prevention. 2009 pandemic influenza A (H1 N1 ) virus infections-Chicago, Illinois, April-July 2009. MMWR Morb Mortal Wkly Rep, 2009, 58:913-918.
  • 10Kitching A, Roche A, Balasegaram S, et al. Osehamivir adherence and side effects among children in three London schools affected by influenza A( H1N1 ) v, May 2009 - an internet-based cross-sectional survey. Euro Surveill,2009,14 : 19287.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部